Literature DB >> 1312609

Mutations in the SH3 domain of the src oncogene which decrease association of phosphatidylinositol 3'-kinase activity with pp60v-src and alter cellular morphology.

D S Wages1, J Keefer, T B Rall, M J Weber.   

Abstract

To analyze the signaling pathways utilized in malignant transformation by pp60v-src, we have isolated and characterized src mutants which possess normal levels of protein tyrosine kinase activity but which cause only a partially transformed phenotype. Our hypothesis is that such mutants are partially defective for transformation because they are defective in their ability to activate specific components of the cellular signaling machinery while still activating others. In this communication, we report on the molecular and biochemical characterization of one such mutant, CU12 (D. D. Anderson, R. P. Beckmann, E. H. Harms, K. Nakamura, and M. J. Weber, J. Virol. 37:455-458, 1981). Cells infected with this mutant are capable of anchorage-independent growth, but rather than exhibiting the rounded and refractile morphology characteristic of wild-type-infected cells, they display an extremely elongated, fusiform morphology. The morphological properties of this mutant src could be accounted for entirely by a single mutation in the SH3 domain (lysine 106 to glutamate). Other mutations were constructed in this region by in vitro mutagenesis, both in a v-src and in an activated c-src background, and several of them also induced a fusiform morphology. All of the mutations inducing fusiform morphology also resulted in decreased association of pp60src with phosphatidylinositol 3'-kinase activity. In addition, association of pp60src with some tyrosine-phosphorylated proteins was altered. We propose that the SH3 domain participates (along with the SH2 domain) in the interaction of pp60src with cellular signaling proteins, and we speculate that the association with phosphatidylinositol 3'-kinase plays an important role in the regulation of cellular morphology.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312609      PMCID: PMC288973     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  67 in total

1.  Dissociation of transformation parameters using temperature-conditional mutants of Rous sarcoma virus.

Authors:  M J Weber; R R Friis
Journal:  Cell       Date:  1979-01       Impact factor: 41.582

2.  Phosphatidylinositol kinase or an associated protein is a substrate for the insulin receptor tyrosine kinase.

Authors:  G Endemann; K Yonezawa; R A Roth
Journal:  J Biol Chem       Date:  1990-01-05       Impact factor: 5.157

3.  Changes in microfilament organization and surface topogrophy upon transformation of chick embryo fibroblasts with Rous sarcoma virus.

Authors:  E Wang; A R Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

4.  Early changes in the distribution and organization of microfilament proteins during cell transformation.

Authors:  C B Boschek; B M Jockusch; R R Friis; R Back; E Grundmann; H Bauer
Journal:  Cell       Date:  1981-04       Impact factor: 41.582

5.  Cloning of a 67-kD neutrophil oxidase factor with similarity to a noncatalytic region of p60c-src.

Authors:  T L Leto; K J Lomax; B D Volpp; H Nunoi; J M Sechler; W M Nauseef; R A Clark; J I Gallin; H L Malech
Journal:  Science       Date:  1990-05-11       Impact factor: 47.728

6.  Inositol trisphosphate levels in cells expressing wild-type and mutant polyomavirus middle T antigens: evidence for activation of phospholipase C via activation of pp60c-src.

Authors:  F R Gorga; C E Riney; T L Benjamin
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

7.  Phosphatidylinositol-3 kinase is activated in v-src, v-yes, and v-fps transformed chicken embryo fibroblasts.

Authors:  Y Fukui; A R Saltiel; H Hanafusa
Journal:  Oncogene       Date:  1991-03       Impact factor: 9.867

8.  Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases.

Authors:  E Y Skolnik; B Margolis; M Mohammadi; E Lowenstein; R Fischer; A Drepps; A Ullrich; J Schlessinger
Journal:  Cell       Date:  1991-04-05       Impact factor: 41.582

9.  Tumorigenicity of partial transformation mutants of Rous sarcoma virus.

Authors:  P Kahn; K Nakamura; S Shin; R E Smith; M J Weber
Journal:  J Virol       Date:  1982-05       Impact factor: 5.103

10.  Monoclonal antibodies to Rous sarcoma virus pp60src react with enzymatically active cellular pp60src of avian and mammalian origin.

Authors:  S J Parsons; D J McCarley; C M Ely; D C Benjamin; J T Parsons
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

View more
  17 in total

1.  Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway.

Authors:  T Skorski; A Bellacosa; M Nieborowska-Skorska; M Majewski; R Martinez; J K Choi; R Trotta; P Wlodarski; D Perrotti; T O Chan; M A Wasik; P N Tsichlis; B Calabretta
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

2.  Identification of Src, Fyn, and Lyn SH3-binding proteins: implications for a function of SH3 domains.

Authors:  Z Weng; S M Thomas; R J Rickles; J A Taylor; A W Brauer; C Seidel-Dugan; W M Michael; G Dreyfuss; J S Brugge
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

3.  The SH3 domain of p56lck is involved in binding to phosphatidylinositol 3'-kinase from T lymphocytes.

Authors:  L B Vogel; D J Fujita
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

Review 4.  Role of tyrosine kinases in lymphocyte activation: targets for drug intervention.

Authors:  J H Hanke; B A Pollok; P S Changelian
Journal:  Inflamm Res       Date:  1995-09       Impact factor: 4.575

5.  The integrity of the SH3 binding motif of AFAP-110 is required to facilitate tyrosine phosphorylation by, and stable complex formation with, Src.

Authors:  A C Guappone; D C Flynn
Journal:  Mol Cell Biochem       Date:  1997-10       Impact factor: 3.396

6.  Transformation by v-Src: Ras-MAPK and PI3K-mTOR mediate parallel pathways.

Authors:  E Penuel; G S Martin
Journal:  Mol Biol Cell       Date:  1999-06       Impact factor: 4.138

7.  Muscarinic receptors transform NIH 3T3 cells through a Ras-dependent signalling pathway inhibited by the Ras-GTPase-activating protein SH3 domain.

Authors:  R R Mattingly; A Sorisky; M R Brann; I G Macara
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

8.  The v-Src SH3 domain binds phosphatidylinositol 3'-kinase.

Authors:  X Liu; L E Marengere; C A Koch; T Pawson
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

9.  Mutations in v-Src SH3 and catalytic domains that jointly confer temperature-sensitive transformation with minimal temperature-dependent changes in cellular tyrosine phosphorylation.

Authors:  A D Catling; V J Fincham; M C Frame; B Haefner; J A Wyke
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

10.  Src-homology 3 domain of protein kinase p59fyn mediates binding to phosphatidylinositol 3-kinase in T cells.

Authors:  K V Prasad; O Janssen; R Kapeller; M Raab; L C Cantley; C E Rudd
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.